A new discovery offers hope for Huntington’s disease. This discovery provides hope that a DNA repair process may help slow or ...
Less than a month after researchers unveiled that a “ticking DNA clock” is behind Huntington’s disease (HD), scientists have ...
Qure's AMT-130 shows 80% Huntington's progress reduction, eyeing FDA approval. Click here to read why I rate QURE stock a Buy ...
William Yang, professor of the UCLA Health Department of Psychiatry and Biobehavioral Sciences and the Terry Semel Chair in Alzheimer's Disease Research and Treatment at the Semel Institute. Yang and ...
Medical Xpress on MSN10d
UCLA study reveals key role of mismatch repair genes in Huntington’s diseaseA new UCLA Health study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are most vulnerable in Huntington's disease ...
Four more experimental drugs for amyotrophic lateral sclerosis (ALS) have failed to hit the primary endpoint in the phase 2/3 ...
17h
News Medical on MSNNeurofilament light as a translational biomarker from preclinical drug discovery to clinical applicationNeurofilament light (NFL) is a powerful and sensitive biomarker for tracking neuronal health and disease progression.
In a recent study, beta blockers appeared to significantly lower both the annualized risk for conversion from presymptomatic to symptomatic Huntington’s disease (HD) and the rate of worsening ...
Su Jin Yim and colleagues argue that with the proposed definition of Alzheimer’s disease (AD) expanding in the most recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results